Cytolytic Assays

Stephen E. Winikoff, Herbert J. Zeh, Richard DeMarco, Michael T. Lotze

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

This chapter provides an overview of cytolytic assays. Cytolytic pathways, although capable of mediating the extrinsic pathway, are primarily induced through perforin-mediated delivery of granzymes. The earliest means to assess cytotoxicity were those related to trypan blue exclusion of nonviable cells and projection of a microscopic field onto a screen for direct visual counting. These were supplanted by a variety of radioactive and fluorescent strategies to facilitate higher throughput and accuracy. The chromium release microcytotoxicity assay (CRA) is the standard and most frequently used assay for assessment of cell-mediated cytotoxicity in vitro. "Europium release assay" is sensitive and specific and performs well with nonadherent tumor cell targets. Additional advantages are the reduced health risk and radioactive waste and lower cost per assay. The "MTT (3-(4,5-dimethylthiazol.2-YL)-2,5-dipheyltetrazolium bromide) assay" relies on the cellular reduction of tetrazolium salts to their formazan crystals. The advantages of the MTT assay include ease and rapidity of performance, reproducibility of the results, and observed clinical correlation between in vitro and in vivo testing. Because of the disadvantages of CRAs, a number of flow cytometry based killing assays are developed. In most of these assays, target cells are stained with individual markers and after incubation with effector cells, target cell lysis is measured.

Original languageEnglish (US)
Title of host publicationMeasuring Immunity
Subtitle of host publicationBasic Biology and Clinical Assessment
PublisherElsevier Ltd.
Pages343-349
Number of pages7
ISBN (Print)9780124559004
DOIs
StatePublished - Dec 1 2005
Externally publishedYes

Fingerprint

Assays
Tetrazolium Salts
Formazans
Cytotoxicity
Europium
Radioactive Waste
Granzymes
Perforin
Trypan Blue
Chromium
Bromides
Reproducibility of Results
Flow Cytometry
Flow cytometry
Health risks
Costs and Cost Analysis
Tumors
Health
Cells
Throughput

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Winikoff, S. E., Zeh, H. J., DeMarco, R., & Lotze, M. T. (2005). Cytolytic Assays. In Measuring Immunity: Basic Biology and Clinical Assessment (pp. 343-349). Elsevier Ltd.. https://doi.org/10.1016/B978-012455900-4/50291-9

Cytolytic Assays. / Winikoff, Stephen E.; Zeh, Herbert J.; DeMarco, Richard; Lotze, Michael T.

Measuring Immunity: Basic Biology and Clinical Assessment. Elsevier Ltd., 2005. p. 343-349.

Research output: Chapter in Book/Report/Conference proceedingChapter

Winikoff, SE, Zeh, HJ, DeMarco, R & Lotze, MT 2005, Cytolytic Assays. in Measuring Immunity: Basic Biology and Clinical Assessment. Elsevier Ltd., pp. 343-349. https://doi.org/10.1016/B978-012455900-4/50291-9
Winikoff SE, Zeh HJ, DeMarco R, Lotze MT. Cytolytic Assays. In Measuring Immunity: Basic Biology and Clinical Assessment. Elsevier Ltd. 2005. p. 343-349 https://doi.org/10.1016/B978-012455900-4/50291-9
Winikoff, Stephen E. ; Zeh, Herbert J. ; DeMarco, Richard ; Lotze, Michael T. / Cytolytic Assays. Measuring Immunity: Basic Biology and Clinical Assessment. Elsevier Ltd., 2005. pp. 343-349
@inbook{14e65cef737746e5956a0865829bb5dd,
title = "Cytolytic Assays",
abstract = "This chapter provides an overview of cytolytic assays. Cytolytic pathways, although capable of mediating the extrinsic pathway, are primarily induced through perforin-mediated delivery of granzymes. The earliest means to assess cytotoxicity were those related to trypan blue exclusion of nonviable cells and projection of a microscopic field onto a screen for direct visual counting. These were supplanted by a variety of radioactive and fluorescent strategies to facilitate higher throughput and accuracy. The chromium release microcytotoxicity assay (CRA) is the standard and most frequently used assay for assessment of cell-mediated cytotoxicity in vitro. {"}Europium release assay{"} is sensitive and specific and performs well with nonadherent tumor cell targets. Additional advantages are the reduced health risk and radioactive waste and lower cost per assay. The {"}MTT (3-(4,5-dimethylthiazol.2-YL)-2,5-dipheyltetrazolium bromide) assay{"} relies on the cellular reduction of tetrazolium salts to their formazan crystals. The advantages of the MTT assay include ease and rapidity of performance, reproducibility of the results, and observed clinical correlation between in vitro and in vivo testing. Because of the disadvantages of CRAs, a number of flow cytometry based killing assays are developed. In most of these assays, target cells are stained with individual markers and after incubation with effector cells, target cell lysis is measured.",
author = "Winikoff, {Stephen E.} and Zeh, {Herbert J.} and Richard DeMarco and Lotze, {Michael T.}",
year = "2005",
month = "12",
day = "1",
doi = "10.1016/B978-012455900-4/50291-9",
language = "English (US)",
isbn = "9780124559004",
pages = "343--349",
booktitle = "Measuring Immunity",
publisher = "Elsevier Ltd.",

}

TY - CHAP

T1 - Cytolytic Assays

AU - Winikoff, Stephen E.

AU - Zeh, Herbert J.

AU - DeMarco, Richard

AU - Lotze, Michael T.

PY - 2005/12/1

Y1 - 2005/12/1

N2 - This chapter provides an overview of cytolytic assays. Cytolytic pathways, although capable of mediating the extrinsic pathway, are primarily induced through perforin-mediated delivery of granzymes. The earliest means to assess cytotoxicity were those related to trypan blue exclusion of nonviable cells and projection of a microscopic field onto a screen for direct visual counting. These were supplanted by a variety of radioactive and fluorescent strategies to facilitate higher throughput and accuracy. The chromium release microcytotoxicity assay (CRA) is the standard and most frequently used assay for assessment of cell-mediated cytotoxicity in vitro. "Europium release assay" is sensitive and specific and performs well with nonadherent tumor cell targets. Additional advantages are the reduced health risk and radioactive waste and lower cost per assay. The "MTT (3-(4,5-dimethylthiazol.2-YL)-2,5-dipheyltetrazolium bromide) assay" relies on the cellular reduction of tetrazolium salts to their formazan crystals. The advantages of the MTT assay include ease and rapidity of performance, reproducibility of the results, and observed clinical correlation between in vitro and in vivo testing. Because of the disadvantages of CRAs, a number of flow cytometry based killing assays are developed. In most of these assays, target cells are stained with individual markers and after incubation with effector cells, target cell lysis is measured.

AB - This chapter provides an overview of cytolytic assays. Cytolytic pathways, although capable of mediating the extrinsic pathway, are primarily induced through perforin-mediated delivery of granzymes. The earliest means to assess cytotoxicity were those related to trypan blue exclusion of nonviable cells and projection of a microscopic field onto a screen for direct visual counting. These were supplanted by a variety of radioactive and fluorescent strategies to facilitate higher throughput and accuracy. The chromium release microcytotoxicity assay (CRA) is the standard and most frequently used assay for assessment of cell-mediated cytotoxicity in vitro. "Europium release assay" is sensitive and specific and performs well with nonadherent tumor cell targets. Additional advantages are the reduced health risk and radioactive waste and lower cost per assay. The "MTT (3-(4,5-dimethylthiazol.2-YL)-2,5-dipheyltetrazolium bromide) assay" relies on the cellular reduction of tetrazolium salts to their formazan crystals. The advantages of the MTT assay include ease and rapidity of performance, reproducibility of the results, and observed clinical correlation between in vitro and in vivo testing. Because of the disadvantages of CRAs, a number of flow cytometry based killing assays are developed. In most of these assays, target cells are stained with individual markers and after incubation with effector cells, target cell lysis is measured.

UR - http://www.scopus.com/inward/record.url?scp=33845874658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845874658&partnerID=8YFLogxK

U2 - 10.1016/B978-012455900-4/50291-9

DO - 10.1016/B978-012455900-4/50291-9

M3 - Chapter

AN - SCOPUS:33845874658

SN - 9780124559004

SP - 343

EP - 349

BT - Measuring Immunity

PB - Elsevier Ltd.

ER -